Implementation of innovative steel processing techniques in the manufacturing plant TYTAX FACTORY ALINA AND STANISŁAW Szulka SRL, which has its registered office: UL. Polish Army 31, 89-632 Brusy to create the technological conditions for activating the production of equipment developed within the framework of the Andros project, intended for exercise in the prevention and treatment of i - Q120832 (Q120832): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Removed claim: summary (P836): The project involves the implementation of innovative steel processing technologies in the production plant, of TITLE X FACTORY ALINA AND STISŁAW Szulka S.C. in order to create the technological conditions for triggering the production of equipment developed within the framework of the Andros research project and intended for exercise in the prevention and treatment of sexual disorders and disorders. Products will be directed to the Polish and...)
Property / summary
The project involves the implementation of innovative steel processing technologies in the production plant, of TITLE X FACTORY ALINA AND STISŁAW Szulka S.C. in order to create the technological conditions for triggering the production of equipment developed within the framework of the Andros research project and intended for exercise in the prevention and treatment of sexual disorders and disorders. Products will be directed to the Polish and foreign markets: USA, EU, Canada, Australia, Saudi Arabia, Gulf countries, Japan, South Korea, India, China, New Zealand. Expected annual increase in sales for the implementation of projektu:3,5 million Project is part of ISP 4 medical technologies for civilisation and ageing diseases (English)
 
Property / summary: The project involves the implementation of innovative steel processing technologies in the production plant, of TITLE X FACTORY ALINA AND STISŁAW Szulka S.C. in order to create the technological conditions for triggering the production of equipment developed within the framework of the Andros research project and intended for exercise in the prevention and treatment of sexual disorders and disorders. Products will be directed to the Polish and foreign markets: USA, EU, Canada, Australia, Saudi Arabia, Gulf countries, Japan, South Korea, India, China, New Zealand. Expected annual increase in sales for the implementation of projektu:3,5 million Project is part of ISP 4 medical technologies for civilisation and ageing diseases (English) / rank
Normal rank
 

Revision as of 07:11, 21 October 2020

Project in Poland financed by DG Regio
Language Label Description Also known as
English
Implementation of innovative steel processing techniques in the manufacturing plant TYTAX FACTORY ALINA AND STANISŁAW Szulka SRL, which has its registered office: UL. Polish Army 31, 89-632 Brusy to create the technological conditions for activating the production of equipment developed within the framework of the Andros project, intended for exercise in the prevention and treatment of i - Q120832
Project in Poland financed by DG Regio

    Statements

    0 references
    1,100,000.0 zloty
    0 references
    264,000.0 Euro
    13 January 2020
    0 references
    2,000,000.0 zloty
    0 references
    480,000.0 Euro
    13 January 2020
    0 references
    55.0 percent
    0 references
    15 March 2017
    0 references
    30 September 2019
    0 references
    TYTAX FACTORY ALINA I STANISŁAW SZULTKA SPÓŁKA CYWILNA
    0 references
    0 references
    Projekt obejmuje wdrożenie innowacyjnych technologii obróbki stali w zakładzie produkcyjnym TYTAX FACTORY ALINA I STANISŁAW SZULTKA S.C. w celu stworzenia warunków technologicznych do uruchomienia produkcji urządzeń opracowanych w ramach projektu badawczego ANDROS, a przeznaczonych do ćwiczeń w profilaktyce i leczeniu inkontynencji i zaburzeń seksualnych. Produkty będą kierowane na rynek polski i zagraniczny: USA, UE, Kanady, Australii, Arabii Saudyjskiej, krajów Zatoki Perskiej, Japoni, Korei Południowej, Indii, Chin, Nowej Zelandii. Oczekiwany roczny wzrost sprzedaży z tytułu realizacji projektu:3,5 mln Projekt wpisuje się w ISP 4 Technologie medyczne w zakresie chorób cywilizacyjnych i okresu starzenia się (Polish)
    0 references

    Identifiers

    RPPM.02.02.01-22-0036/17
    0 references